iBio, Inc. (IBIO)
1.705
-0.02
(-1.45%)
USD |
NASDAQ |
Jun 09, 16:00
1.705
0.00 (0.00%)
After-Hours: 18:57
iBio SG&A Expense (Quarterly) : 5.111M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | 9.396M |
| Ocugen, Inc. | 8.117M |
| CytomX Therapeutics, Inc. | 10.69M |
| ACADIA Pharmaceuticals, Inc. | 171.02M |
| Alnylam Pharmaceuticals, Inc. | 322.55M |